3Jadwiga A Wedzicha,Terence AR Seemungal.COPD exacerbations: defining their cause and prevention[J]. The Lancet . 2007 (9589) 被引量：2
4Beuscher N,Kietzmann M,Bien E,Champeroux P.Interference of myrtol standardized with inflammatory and allergic mediators. Arzneimittel Forschung Drug Research . 1998 被引量：1
5Matthys H, de Mey C, Carls C, et al, Efficacy and tolerability ofmyrtol standardized in acute bronchitis [J]. Arzneimittelforschung, 2000, 50 (8):700-711. 被引量：1
6UlmerWT, SchottD. Chronic obstructive bronchitis. Effect of Gelomyrtol forte in a p lacebocontrolled double2blind study [J].Fortschr Med, 1991, 109 (27): 547-550. 被引量：1
7Sengespeik HC, Zimmermann T, Peike C, et al. Myrtol standardized in the treatment of acute and chronic respiratory infections in children [J]. Arzneimittelforschung, 1998, 48 (10) : 990-994. 被引量：1
8Meister R, Wittig T, BeuscherN, et al. Efficacy and tolerability ofmyrtol standardized in longterm treatment of chronic bronchitis. A double blind, placebocontrolled study. Study Group Investigators[J]. Arzneimittelforschung, 1999, 49 ( 4 ): 351-358. 被引量：1
9Beuscher N, Kietzmann M, Bien E, et al. Interference of Myrtol Standardized with Inflammatory and Allergic Mediators [J].Arzneimittelforsehung, 1998, 48 (10): 985-989. 被引量：1
10Behrbohm H, Kasehke O, Sydow K. The influence of a secre tolytic drug on mucociliary clearance of the maxillary sinus[J].J Rhinol, 1997, 4 (1): 29 -33. 被引量：1
